Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MBLAC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MAD2L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXCL10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ILDR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C22orf46 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ULK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC389834 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
SH3PXD2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDGFRP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCL9L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLXNB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TFCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELAVL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AFDN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DGKQ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on